HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
Xylometazolin
XYLOMETAZOLINE · Otrix · Otriven · Otrivin · Ba-11391 · Otrivine · Rhinoxilin · Xylomethazoline

Identifikatoren & physikalische Daten
| CAS No. | 526-36-3 |
|---|---|
| Summenformel | C16H24N2 |
| Durchschnittliche Molmasse | 244,37 g/mol |
| Monoisotopische Masse | 244,19394877 g/mol |
| SMILES | Cc1cc(C(C)(C)C)cc(C)c1CC1=NCCN1 |
| InChIKey | HUCJFAOMUPXHDK-UHFFFAOYSA-N |
| PubChem CID | 5709 |
| ChEMBL | CHEMBL312448 |
| ChEBI | CHEBI:10082 |
| EC No. | 208-390-6 |
| DTXSID | DTXSID8046957 |
| Lokaler Name | Xylometazolin |
Chemische & physikalische Eigenschaften
| XLogP | 3,2 |
|---|---|
| Polarare Oberfläche (TPSA) | 24,4 |
| H-Brücken-Donoren | 1 |
| H-Brücken-Akzeptoren | 1 |
| Frei drehbare Bindungen | 3 |
| Schwere Atome | 18 |
| Formalladung | 0 |
| Komplexität | 302 |
| Arzneimittel | Pharmaceuticals -> Listed in ZINC15 |
| LogP (Verteilungskoeffizient) | 3.2 |
| Human Drugs | Breast FeedingLactationMilk, HumanAdrenergic alpha-AgonistsSympathomimeticsNasal DecongestantsPharmaceuticalsEar, nose and throat medicines [c] |
| Schmelzpunkt | 317-329131 - 133 °C131-133° |
| Physical Description | Solid |
| Collision Cross Section | 161.58 Ų [M+Na]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards]170.4 Ų [M+H]+ [CCS Type: TWMethod: Major Mix IMS/Tof Calibration Kit (Waters)] |
| Siedepunkt | 394.2±21.0 °C(Predicted) |
| Dichte | 1.00±0.1 g/cm3(Predicted) |
| Lagerbedingungen | Store at -20°C |
| Löslichkeit | DMSO: 49 mg/mL (200.51 mM)Ethanol: 49 mg/mL (200.51 mM)Water: Insoluble |
| pKa (Säurekonstante) | pKa 10.6±0.1(H2O t = 22.0) (Uncertain) |
| InChI | InChI=1S/C16H24N2/c1-11-8-13(16(3,4)5)9-12(2)14(11)10-15-17-6-7-18-15/h8-9H,6-7,10H2,1-5H3,(H,17,18) |
| InChIKey | HUCJFAOMUPXHDK-UHFFFAOYSA-N |
| SMILES | C1(CC2=C(C)C=C(C(C)(C)C)C=C2C)NCCN=1 |
| CAS Datenbank | 526-36-3 |
Sicherheit & Vorschriften
| Regulatorische Informationen | Chemical: 1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro- |
|---|---|
| Weitere Sicherheitsinformationen | IMAP assessments - 1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-: Environment tier I assessment |
| Drug Induced Liver Injury | Drug-Induced Liver Injury Severity and Toxicity (DILIst)XylometazolineDILI PositiveDOI:10.1016/j.drudis.2019.09.022 |
| Effects During Pregnancy and Lactation | ◉ Summary of Use during Lactation |
| Toxizität | LD50 oral in mouse: 215mg/kg |
Anwendungen & Verwendung
Verwenden
Adrenergic (vasoconstrictor).